Parathyroid Diseases clinical trials

The registry lists 54 studies for Parathyroid Diseases across more than 10 countries. 6 are recruiting or about to start. 13 of them are mainly about Parathyroid Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 7 narrower conditions too, such as Hyperparathyroidism, Secondary: 648 studies, 118 open.

Get an email when these change. Save the Parathyroid Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 34
Status unknown: 6
Recruiting: 5
Terminated: 5
Active, not recruiting: 2
Enrolling by invitation: 1

Phase

Phase 3: 10
Phase 2: 3
Phase 1: 3
Phase 4: 3

Where

United States: 26
Italy: 4
Canada: 4
France: 4
Denmark: 4
China: 4

Who runs them

OPKO IP Holdings II, Inc. (5) · M.D. Anderson Cancer Center (4) · University of Arkansas (3) · University Hospital Sestre Milosrdnice (2) · OPKO Health, Inc. (2) · National Taiwan University Hospital (2) · IHU Strasbourg (2) · Ascendis Pharma Bone Diseases A/S (2)

What is being tested here

Drugs under test in Parathyroid Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Palopegteriparatide	1	3	4
Modified-release Calcifediol Capsule	0	3	4
Calcifediol	0	3	4
Ropivacaine	0	0	1
Acetaminophen	0	0	1
Tramadol	0	0	1
Fluciclovine F-18	0	0	1
Biotin	0	0	1
Cefazolin	0	0	1
Dexamethasone	0	0	1

Coming up

2phase 3 studies under way

2studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2, phase 3 first

Jun 2027A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism · Phase 3 · Ascendis Pharma Bone Diseases A/S
Nov 2027Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach · Sarasota Memorial Health Care System

Who these studies take

Of the 5 Parathyroid Diseases studies recruiting now, 4 (80%) set no upper age limit and 1 (20%) stop at 75 or younger. 2 (40%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	2 (40%)	2 (40%)
18	5 (100%)	5 (100%)
30	5 (100%)	5 (100%)
40	5 (100%)	5 (100%)
50	5 (100%)	5 (100%)
65	4 (80%)	4 (80%)
75	4 (80%)	4 (80%)
85	4 (80%)	4 (80%)

Across all 54 studies, recruiting or not: 9% stop at 75 or younger and 4% at 65; 11% take children; 2% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 → or search them.